Champions Oncology Corp (CSBR) - Forvard P/S multiplikatori

Champions Oncology Inc (CSBR) kompaniyasining rasmiy ramzlari

Champions Oncology biznesining past siklligi onkologik tadqiqotlar uchun barqaror moliyalashtirish bilan ta'minlanadi. Bashorat qilingan P/S tendentsiyasi ushbu asosni vizuallashtiradi, bunda 1.10 bazaviy qiymat sifatida qayd etilgan. Oqimlarning o'rtacha barqarorligi muntazam dori vositalarini sinovdan o'tkazish buyurtmalariga tayanadi. Kompaniyaning ekologik profili biosafety qoidalariga qat'iy rioya qilish va chiqindilarni tegishli ravishda utilizatsiya qilish bilan cheklangan.

CSBR Champions Oncology Inc: Forvard narx/daromad multiplikatori 04.07.2022 - 17.11.2026 oraligʻida

Champions Oncology kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning dastlabki tahlili:CSBR (Champions Oncology Inc)
Champions Oncology, Inc. tovar namunasi

Forward P/S kompaniyaning bozor qiymatini kutilayotgan daromadga nisbatan belgilaydi va investorlarning biznesning kengayish salohiyati uchun qo'shimcha to'lov qilishga tayyorligini o'lchaydi. Forward P/S metrikasini tahlil qilish orqali Champions Oncology (CSBR) kompaniyasining savdo premiumining asoslanganligini baholash mumkin, bu esa PDX modellarining eksklyuzivligi va prognozlarning aniqligi tufayli sog'liqni saqlash gigantlari ustidan narxlarni belgilash imkoniyatiga ega ekanligi bilan bog'liq.

Champions Oncology raqobatchilari tahlili

Forvard P/S multiplikatori ONC (BeiGene Oncology)|Forvard P/S multiplikatori Halozyme Corp HALO|RVMD: Forvard narx/daromad multiplikatori|Ascentage Pharma Group (AAPG) - Forvard narx/daromad multiplikatori|CG Oncology Therapeutics (CGON) - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati UroGen Pharma URGN|Narxning prognoz qilingan daromadga nisbati Bicara Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Personalis Genomics PSNL|Forvard P/S multiplikatori ERAS|Narxning kutilayotgan daromadga nisbati DCTH|Y-mAbs Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aura Biosciences Inc (AURA)|CADL: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ARAY (Accuray Inc.)|SLS: Forvard P/S multiplikatori|ACTU: Narxning kutilayotgan daromadga nisbati|CTOR (Citius Oncology Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati tuhurabio.com HURA|Forvard P/S multiplikatori TARA|FATE: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori WHWK (Aadi Bioscience)|TCRX (TScan) - Kelajakdagi narxning daromadga nisbati|XBIT: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx CVM (cel-sci.com)|OSTX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Radiopharm Theranostics Ltd (RADX)|ARTV (Artiva) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ANL (Adlai Nortye)|Narxning prognoz qilingan daromadga nisbati Veru Pharma (VERU)|Forvard P/S multiplikatori Tempest Tx (TPST)|Narxning prognoz qilingan daromadga nisbati xiliotx.com XLO|Enochian BioSciences - Narxning prognoz qilingan daromadga nisbati|Mural Oncology - Forvard P/S multiplikatori|KAPA - Forvard P/S multiplikatori|OnKure Therapeutics Inc (OKUR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori CytoMed|Narxning prognoz qilingan daromadga nisbati curis.com|Forvard narx/daromad multiplikatori Apollomics, Inc. (APLM)|Forvard P/S multiplikatori THAR|Advanced Biomed Corp - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Genprex GNPX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Calidi Bio (CLDI)|sunshinebiopharma.com - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati xeneticbio.com|salariuspharma.com (SLRX) - Narxning prognoz qilingan daromadga nisbati|Purple Biotech Ltd. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati AON|Forvard P/S multiplikatori BeiGene Ltd.|Narxning prognoz qilingan daromadga nisbati Checkpoint Therapeutics, Inc. (CKPT)|Forvard narx/daromad multiplikatori Elevation Oncology, Inc. ELEV|Forvard P/S multiplikatori ICAD (iCAD Inc.)|IKNA - Forvard narx/daromad multiplikatori|NTBL: Forvard narx/daromad multiplikatori|viracta.com (VIRX) - Forvard narx/daromad multiplikatori|MorphoSys (MOR) - Narxning prognoz qilingan daromadga nisbati|NAYA Biosciences Corp (NAYA) - Forvard P/S multiplikatori|AAPGV (Ascentage) - Forvard P/S multiplikatori